Cargando…

Pexidartinib in the Management of Advanced Tenosynovial Giant Cell Tumor: Focus on Patient Selection and Special Considerations

Tenosynovial giant cell tumor (TGCT) is a neoplasm of the joint synovium that can have severe impacts on joint mobility, function, and quality of life. Traditionally, treatment modalities included partial or complete surgical synovectomy, radiotherapy (typically as an adjunct to surgery), and watchf...

Descripción completa

Detalles Bibliográficos
Autores principales:	Vaynrub, Anna, Healey, John H, Tap, William, Vaynrub, Max
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Dove 2022
Materias:	Review
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8763255/ https://www.ncbi.nlm.nih.gov/pubmed/35046667 http://dx.doi.org/10.2147/OTT.S345878

Ejemplares similares

Long‐term outcomes of pexidartinib in tenosynovial giant cell tumors
por: Gelderblom, Hans, et al.
Publicado: (2020)

Exposure–response analysis of efficacy and safety for pexidartinib in patients with tenosynovial giant cell tumor
por: Yin, Ophelia, et al.
Publicado: (2021)

Pexidartinib Long‐Term Hepatic Safety Profile in Patients with Tenosynovial Giant Cell Tumors
por: Lewis, James H., et al.
Publicado: (2020)

Population Pharmacokinetic Analysis of Pexidartinib in Healthy Subjects and Patients With Tenosynovial Giant Cell Tumor or Other Solid Tumors
por: Yin, Ophelia, et al.
Publicado: (2020)

Complementary Effects of Surgery and Pexidartinib in the Management of Patients with Complex Diffuse-Tenosynovial Giant Cell Tumor
por: Bernthal, Nicholas M., et al.
Publicado: (2022)

Pexidartinib improves physical functioning and stiffness in patients with tenosynovial giant cell tumor: results from the ENLIVEN randomized clinical trial
por: Van De Sande, Michiel, et al.
Publicado: (2021)

Pexidartinib (TURALIO™): The First FDA-Indicated Systemic Treatment for Tenosynovial Giant Cell Tumor
por: Monestime, Shanada, et al.
Publicado: (2020)

Tenosynovial giant cell tumor: case report of a patient effectively treated with pexidartinib (PLX3397) and review of the literature
por: Giustini, Nicholas, et al.
Publicado: (2018)

Patient-reported Symptoms of Tenosynovial Giant Cell Tumors
por: Gelhorn, Heather L., et al.
Publicado: (2016)

Management of Tenosynovial Giant Cell Tumor: A Neoplastic and Inflammatory Disease
por: Healey, John H., et al.
Publicado: (2020)

Anti-IL17 antibody Secukinumab therapy is associated with ossification in giant cell tumor of bone: a case report of pathologic similarities and therapeutic potential similar to Denosumab
por: Chandler, Andrew, et al.
Publicado: (2021)

Novel CSF1R-positive tenosynovial giant cell tumor cell lines and their pexidartinib (PLX3397) and sotuletinib (BLZ945)-induced apoptosis
por: Thongchot, Suyanee, et al.
Publicado: (2022)

Pexidartinib, a Novel Small Molecule CSF-1R Inhibitor in Use for Tenosynovial Giant Cell Tumor: A Systematic Review of Pre-Clinical and Clinical Development
por: Benner, Brooke, et al.
Publicado: (2020)

Localized tenosynovial giant cell tumor in children
por: Du, Xifeng, et al.
Publicado: (2023)

Percutaneous lumbopelvic fixation for pathologic sacral fractures and spinopelvic dissociation: patient series
por: Baksh, Nikolas, et al.
Publicado: (2023)

The measurement of physical functioning among patients with Tenosynovial Giant Cell Tumor (TGCT) using the Patient-Reported Outcomes Measurement Information System (PROMIS)
por: Gelhorn, Heather L., et al.
Publicado: (2019)

Tenosynovial Giant Cell Tumor Arising on the Scapular Region
por: Fukuda, Asako, et al.
Publicado: (2013)

Diffuse Type Tenosynovial Giant Cell Tumor of the Ankle
por: Zhao, Jing-Jing, et al.
Publicado: (2016)

Cryosurgery as Additional Treatment in Tenosynovial Giant Cell Tumors
por: Verspoor, F. G. M., et al.
Publicado: (2016)

Chondroid Tenosynovial Giant Cell Tumor of Temporomandibular Joint
por: Shetty, Sujeeth Kumar, et al.
Publicado: (2018)

Intramuscular Tenosynovial Giant Cell Tumor, Diffuse-Type
por: Lee, Yoo Jin, et al.
Publicado: (2016)

Tenosynovial giant cell tumor of the distal tibiofibular joint
por: Zarate, Stephanie D., et al.
Publicado: (2021)

Tenosynovial giant cell tumor of the posterior pharyngeal space
por: Poutoglidis, Alexandros, et al.
Publicado: (2022)

Expanding the molecular spectrum of tenosynovial giant cell tumors
por: Gauduchon, Thibault, et al.
Publicado: (2022)

Tenosynovial giant cell tumor: a case report
por: Ansel, Sonam, et al.
Publicado: (2023)

Pexidartinib: First Approval
por: Lamb, Yvette N.
Publicado: (2019)

Long-term efficacy of imatinib mesylate in patients with advanced Tenosynovial Giant Cell Tumor
por: Verspoor, F. G. M., et al.
Publicado: (2019)

Localized Giant Cell Tenosynovial Tumor Seen in the Knee Joint
por: Beytemür, Ozan, et al.
Publicado: (2014)

Tenosynovial Giant-Cell Tumor Presenting as Septic Arthritis of the Knee
por: Lausé, Gregory E., et al.
Publicado: (2021)

Tenosynovial Giant Cell Tumor After ACL Reconstruction With Autograft
por: Booth, Michael, et al.
Publicado: (2022)

PD-L1 Status in Tenosynovial Giant Cell Tumors
por: Zenginkinet, Tulay, et al.
Publicado: (2022)

Interactions in CSF1-Driven Tenosynovial Giant Cell Tumors
por: van IJzendoorn, David G.P., et al.
Publicado: (2022)

A Phase I Study of Binimetinib (MEK162) Combined with Pexidartinib (PLX3397) in Patients with Advanced Gastrointestinal Stromal Tumor
por: Rosenbaum, Evan, et al.
Publicado: (2019)

Correction to: Pexidartinib: First Approval
por: Lamb, Yvette N.
Publicado: (2020)

Tenosynovial giant cell tumor of the cervical spine: a case report
por: Furuhata, Ryogo, et al.
Publicado: (2019)

Update on Tenosynovial Giant Cell Tumor, an Inflammatory Arthritis With Neoplastic Features
por: Robert, Marie, et al.
Publicado: (2022)

Tenosynovial, Diffuse Type Giant Cell Tumor of the Temporomandibular Joint, Diagnosis and Management of a Rare Tumor
por: Bredell, Marius, et al.
Publicado: (2015)

Effect of Mild and Moderate Hepatic Impairment (Defined by Child–Pugh Classification and National Cancer Institute Organ Dysfunction Working Group Criteria) on Pexidartinib Pharmacokinetics
por: Zahir, Hamim, et al.
Publicado: (2022)

The diffuse-type tenosynovial giant cell tumor (dt-TGCT) patient journey: a prospective multicenter study
por: Bernthal, Nicholas M., et al.
Publicado: (2021)

Chondroid tenosynovial giant cell tumour of the temporomandibular joint
por: Kanbour, Abdullah, et al.
Publicado: (2021)

Cannot write session to /tmp/vufind_sessions/sess_4i5o5q2s0dtm6aclacrqob5559